In the last five years DMD research has accelerated, a better knowledge of the role of the dystrophin gene and a better understanding of what to muscle cell lacking the dystrophin protein. Examine researchers worldwide a number of different treatment strategies, all of which is aimed at slowing or stopping muscle degeneration. Several clinical trials are underway and many more are in development, including consideration of an oral medication mutations in the dystrophin to circumvent increase increase normal gene expression.
Talamini will assume the position of President of the Society of American Gastrointestinal Endoscopic Surgeons and in Philadelphia in the second week of April 2008. SAGES represents a worldwide community of surgeons that bring minimal access surgery, endoscopy and new techniques. Patients in every country.Latest preclinical data one of the Company under SBIR grant advanced show can enhance that the local ischaemia significantly Ad5 transfection of in the heart in conjunction with intracoronary infusion therapy which indicates that cardiac stimulation has in association to the administration of Generx potential to dramatically improve the therapeutic effect of at a specific dose of.